Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prevalence of statin and beta-blocker use by clinical presentation

Similar presentations


Presentation on theme: "Prevalence of statin and beta-blocker use by clinical presentation"— Presentation transcript:

1 Prevalence of statin and beta-blocker use by clinical presentation
Treatment Acute MI, n=916* Stable angina, n=468† p Statin (%) 19.3 40.4 <0.001 Beta blocker (%) 19.0 47.7 *Men aged 45–75 and women aged 55–75 years †Men and women aged 18–75 Go AS et al. Ann Intern Med 2006; 144:

2 Adjusted risk of presentation with acute MI vs stable angina by treatment and history
Parameter HR (95% OR) Recent statin use 0.45 (0.32–0.62) Recent beta blocker use 0.26 (0.19–0.35) Recent CCB use 1.62 (1.01–2.59) Prior hypertension 1.92 (1.35–2.73) Prior diabetes 1.69 (1.15–2.49) Male sex 1.89 (1.37–2.56) Former cigarette smoking 1.35 (1.01–1.79) Current cigarette smoking 1.72 (0.99–2.97) CCB=calcium-channel blocker Model adjusted for use of any studied medication classes; age; sex; ethnicity; parental CAD history; smoking status; previous alcohol use; physical activity level; previous stroke, peripheral artery disease, hypertension, or HF hospitalization; diabetes; dementia; depression; and other factors Go AS et al. Ann Intern Med 2006; 144:


Download ppt "Prevalence of statin and beta-blocker use by clinical presentation"

Similar presentations


Ads by Google